Coffee Cell Culture Scale-Up Moves Forward as Illuminated Fermentation Enters Commercial Discussion

A new collaboration between Brevel and coffee cell-culture developer Coffeesai points to a growing area of interest for nutraceutical and functional ingredient manufacturers: whether plant cell culture can move beyond laboratory proof-of-concept and into commercially relevant production systems.

The partnership centers on the use of “illuminated fermentation,” a production approach designed to combine fermentation with controlled light exposure to support plant cell growth and influence metabolite output.¹

For manufacturers watching the intersection of food tech, nutraceutical ingredients, and climate-resilient sourcing, the announcement is notable less for the partnership itself than for the manufacturing question it seeks to address. Coffee remains a high-value crop with well-documented supply chain volatility tied to environmental conditions, agricultural constraints, and price fluctuations. If coffee cell culture can be scaled in a controlled indoor system, it may offer a future route to more standardized supply of coffee-derived biomass and bioactive compounds.

Brevel framed the collaboration as a test of whether its fermentation infrastructure can support commercial-scale production of coffee cell cultures. “Our work in coffee cell cultures serve as a case study for the capabilities of our illuminated fermentation infrastructure,” explains Yonatan Golan, CEO and co-founder of Brevel. “Our recent work has demonstrated the platform's ability to achieve high cell densities while sustaining continuous growth through an advanced semi-continuous cultivation process, paving the way for scalable and efficient production.”

What Is Illuminated Fermentation, and Why Does It Matter for Ingredient Manufacturing?

Plant cell culture is being explored as a way to produce plant-derived materials without relying on conventional field agriculture. Rather than cultivating a full crop, manufacturers grow plant cells in suspension under controlled conditions, with the goal of generating target compounds or biomass in a more predictable environment. In theory, that approach can reduce dependence on weather, land availability, and seasonal growing cycles.^1,2

Brevel’s model adds light to the fermentation process. According to the press release,¹ the platform is intended to expose cells to defined light conditions inside the fermenter, with the aim of supporting growth while also affecting production of desirable compounds. In the Coffeesai work, Brevel said success was defined by stable, high-density cultivation along with “measurable, light-dependent improvements in the quality attributes of the biomass.”

That premise aligns with a broader commercial challenge in plant cell culture: producing enough material, with enough consistency, to justify use in finished products. For nutraceutical manufacturers, the appeal of cell culture is not simply sustainability positioning. It is the possibility of more standardized ingredient composition, year-round manufacturing, and better control over contaminants and process variables than may be possible in some agricultural supply chains.

Why Is Coffee Becoming a Target for Plant Cell-Culture Production?

Coffee is a logical case study because it combines strong global demand with a complex agricultural supply chain. Ingredient developers and finished product manufacturers already work with coffee across multiple formats, from beverage applications to energy, cognitive health, and sports nutrition products. That makes coffee-derived biomass an attractive test case for cell-culture systems that aim to deliver controlled production of flavor compounds, caffeine-containing materials, or other bioactive constituents.

Coffeesai’s interest appears to be both operational and sensory. The companies said controlled light exposure may influence flavor and aroma characteristics by modulating expression of compounds in the biomass.¹ That matters because coffee cell culture is unlikely to be judged on yield alone; any future commercial application will also depend on whether the resulting material can deliver a useful sensory profile or functional value in end products.

“We are encouraged by the initial results from Brevel's platform and its potential to influence certain aspects of the sensory profile,” notes Ami Herman, CEO of Coffeesai. “We continue to evaluate its capabilities as we advance our development efforts and determine future production pathways.”

How Could This Affect Nutraceutical and Functional Product Developers?

The immediate impact is limited, as this is an early-stage collaboration rather than a regulatory approval, commercialization launch, or finished clinical package. Still, the announcement is relevant to manufacturers because it illustrates where fermentation infrastructure may be moving next.

Brevel has already discussed applying illuminated fermentation to chlorella production for nutraceutical use, positioning the platform as a way to support controlled indoor cultivation of nutrient-dense biomass.² Extending that concept to plant cell culture suggests a broader manufacturing service model for ingredients that are difficult to source, difficult to standardize, or vulnerable to agricultural disruption.

From a formulation perspective, coffee cell-culture biomass could eventually be relevant to categories such as energy, cognitive health, sports nutrition, and functional beverages, depending on composition, safety, and regulatory positioning.

References

1. Brevel, Ltd. Brevel, Coffeesai team up to optimize production with illuminated fermentation. PR Newswire. June 23, 2026. Accessed June 23, 2026. https://www.prnewswire.com/news-releases/brevel-coffeesai-team-up-to-optimize-production-with-illuminated-fermentation-302807549.html

2. Brevel, Ltd. Brevel’s illuminated fermentation brings pure chlorella to the nutraceutical space. PR Newswire. March 3, 2026. Accessed June 23, 2026. https://www.prnewswire.com/news-releases/brevels-illuminated-fermentation-brings-pure-chlorella-to-the-nutraceutical-space-302702324.html